Fill volume: unknown.Flow rate: unknown.Procedure: unknown.Cathplace: unknown.Infusion start time: unknown.Infusion stop time: unknown.Fda medwatch / fda user facility report # mw 5088912 received on 27-aug-2019, and the following information was provided: "the on-q pump pain relief system was inadvertently connected to the pt's hickman catheter than the right chest on-q catheter.We believe this error was due in part to the ability to easily connect the two devices.The pt's [patient's] pain control was initially provided via epidural catheter, however, following removal of the epidural catheter, the plan was to begin continuous pain relief via the on-q pain relief system.The on-q catheter was present but not visible to the nurse and had not been used up until this point.The nurse was unfamiliar with on-q pumps and assumed the on-q pain relief system should be connected to the hickman catheter.The pt received ropivacaine via the hickman times four hours before the error was identified and corrected.There was no adverse outcome as a result of this event.Our concern was the ability to easily connect the two devices." additional information received 09-sep-2019 indicated that the patient was discharged home on (b)(6) 2019.The patient did not have an adverse outcome as a result of this event; however, "our concern was the ease in which the misconnection occurred.".
|